Lifeway Foods pushes back on Danone hostile takeover, reports record 2024 and 17% weekly sales growth

Lifeway Foods, Inc.

Danone filed Schedule 13D referencing lawsuit; Lifeway calls it hostile takeover at undervalued price.
Lifeway reports unaudited 2024 record revenue, net income, and EBITDA.
Last week of Feb 2025 gross sales $4,543,297, up 17% YoY from $3,880,625.
Lifeway intends to file counterclaim against Danone and aggressively contest claims.
Board committed to maximizing shareholder value; will not be pressured into undervalued deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.